SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 53 filers reported holding SQZ BIOTECHNOLOGIES CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $129 | -70.3% | 1,606,309 | 0.0% | 0.01% | -53.8% |
| Q2 2023 | $434 | -51.8% | 1,606,309 | 0.0% | 0.01% | -75.5% |
| Q1 2023 | $900 | -24.3% | 1,606,309 | 0.0% | 0.05% | -19.7% |
| Q4 2022 | $1,189 | -100.0% | 1,606,309 | 0.0% | 0.07% | -57.7% |
| Q3 2022 | $3,662,000 | -28.3% | 1,606,309 | 0.0% | 0.16% | -42.9% |
| Q2 2022 | $5,108,000 | -33.9% | 1,606,309 | 0.0% | 0.27% | -15.5% |
| Q1 2022 | $7,726,000 | -46.1% | 1,606,309 | 0.0% | 0.32% | -17.0% |
| Q4 2021 | $14,344,000 | -38.1% | 1,606,309 | 0.0% | 0.39% | -24.9% |
| Q3 2021 | $23,163,000 | -0.2% | 1,606,309 | 0.0% | 0.52% | +10.0% |
| Q2 2021 | $23,211,000 | +5.6% | 1,606,309 | 0.0% | 0.47% | +21.4% |
| Q1 2021 | $21,974,000 | -52.8% | 1,606,309 | +0.0% | 0.39% | -61.2% |
| Q4 2020 | $46,551,000 | – | 1,606,308 | – | 1.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGER MANAGEMENT, LLC | 807,827 | $23,411,000 | 1.79% |
| Alphabet Inc. | 831,389 | $24,094,000 | 1.16% |
| Artal Group S.A. | 1,606,308 | $46,551,000 | 1.00% |
| 683 Capital Management, LLC | 466,176 | $13,510,000 | 0.64% |
| MAVERICK CAPITAL LTD | 935,971 | $27,124,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 2,513,924 | $72,854,000 | 0.31% |
| CAAS CAPITAL MANAGEMENT LP | 150,000 | $4,347,000 | 0.04% |
| HRT FINANCIAL LP | 17,456 | $505,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 11,660 | $350,000 | 0.01% |
| Hudock, Inc. | 350 | $10,000 | 0.00% |